EU industry association MedTech Europe has issued a highly critical and unequivocal statement about the EU’s forthcoming regulation on health technology assessment (HTA). The trade body questioned whether it has any value in improving patient access to innovative medtech products and fears it would just add “another level of bureaucracy for medtech to overcome”.
The group says the regulation, which formalizes the EU’s agreement on closer collaboration between member states on HTA, does not...